|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.9500 - 1.9750|
|52 Week Range||1.2900 - 4.4900|
|Beta (5Y Monthly)||0.90|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 17, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Conference Call Scheduled for Wednesday, April 21st at 4:30pm ETSOUTH EASTON, MA / ACCESSWIRE / April 19, 2021 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2020 financial results and to provide a business update.
Company Expects Acquisition to be Accretive with Sustained Profitable Revenue Growth, Leveraging Market-Changing Synergy from PBI's Ultra Shear Technology Nanoemulsions PlatformSOUTH EASTON, MA / ACCESSWIRE / April 14, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, today announced it has finalized terms and executed a new letter of intent to purchase the assets of an internationally-based developer and supplier of organically natural, eco-friendly agrochemicals.
Phoenix, Arizona--(Newsfile Corp. - March 15, 2021) - The Stock Day Podcast welcomed back Pressure BioSciences, Inc. (OTCQB: PBIO) ("the Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services for the worldwide life sciences and other industries. President and CEO of the Company, Richard T. Schumacher, joined Stock Day host Everett Jolly, and offered a detailed update of measurable progress the Company has ...